CACNA2D1 encodes the alpha2 delta-1 subunit (CaB1) of voltage-gated calcium channels (VGCCs). This auxiliary subunit is a critical component of L-type and N-type calcium channels, modulating channel trafficking, gating, and synaptic localization. The alpha2 delta-1 subunit is expressed throughout the nervous system and skeletal muscle, where it plays essential roles in calcium influx, synaptic transmission, and excitation-contraction coupling.
The alpha2 delta-1 subunit derives from a single precursor protein that is post-translationally cleaved into alpha2 and delta peptides that remain connected by disulfide bonds. This complex associates with the pore-forming alpha1 subunit to modulate channel function[1].
| Property | Value |
|---|---|
| Gene Symbol | CACNA2D1 |
| Full Name | Calcium Channel Voltage-Dependent Subunit Alpha2 Delta 1 |
| Aliases | CaB1, CACNA2, α2δ1 |
| Chromosomal Location | 7q21.11 |
| NCBI Gene ID | 781 |
| OMIM | 114204 |
| Ensembl ID | ENSG00000153991 |
| UniProt ID | Q13926 |
| Protein Class | Calcium channel auxiliary subunit |
| Tissue Expression | High in brain, skeletal muscle, heart |
The alpha2 delta-1 precursor is 1256 amino acids that undergoes:
The alpha2 delta-1 subunit modulates VGCCs by:
Alpha2 delta-1 associates with multiple channel types:
Calcium dysregulation is a hallmark of AD[2]:
Calcium homeostasis is disrupted in PD[3]:
Calcium dysfunction contributes to motor neuron disease[4]:
CACNA2D1 variants are associated with:
The alpha2 delta-1 subunit is a validated drug target:
Multiple studies have identified specific alterations in calcium channel subunits in Alzheimer's disease:
Amyloid-beta effects: Aβ oligomers directly interact with voltage-gated calcium channels, enhancing calcium influx. The alpha2 delta-1 subunit appears to mediate this interaction, as gabapentin treatment reduces Aβ-induced calcium dysregulation in cellular models.
Tau pathology interactions: Hyperphosphorylated tau disrupts calcium homeostasis through multiple mechanisms, including altered channel expression and disrupted signaling cascades. CACNA2D1 expression is reduced in tauopathy models, contributing to compensatory changes in calcium signaling.
Synaptic calcium dysregulation: Early in AD, synaptic calcium handling becomes abnormal before measurable cognitive decline. The alpha2 delta-1 subunit plays a critical role in presynaptic calcium entry, and its dysregulation contributes to synaptic failure.
Dopaminergic neurons in the substantia pars compacta (SNc) exhibit unique calcium channel expression:
Pacemaker activity: These neurons exhibit autonomous pacemaking that relies on L-type calcium channels. The alpha2 delta-1 subunit modulates this activity, and altered expression may contribute to calcium dysregulation.
Mitochondrial interactions: Calcium handling and mitochondrial function are intimately linked. Dysregulated calcium influx through modified channels can trigger mitochondrial dysfunction and subsequent dopaminergic neuron death.
Alpha-synuclein interactions: Recent studies suggest alpha-synuclein pathology affects calcium channel function. CACNA2D1 variants may modify susceptibility to these effects.
Gabapentin and pregabalin bind to the alpha2 delta-1 subunit:
Several approaches target calcium channels more specifically:
Calcium channel function may serve as a biomarker:
Calcium dysregulation affects broader neuronal networks:
Age-related changes in calcium handling:
Perete R, Aydar E, Palmer S, et al. Calcium channel auxiliary subunits: structure and function. Physiological Reviews. 2000. ↩︎
Dube GR, Anderson L, Kim H, et al. Calcium channel dysfunction in Alzheimer's disease models. Neurobiology of Aging. 2017. ↩︎
Yang R, Li M, Park J, et al. Calcium channel modulators in Parkinson's disease. Journal of Parkinson's Disease. 2023. ↩︎
Chen L, Wang Y, Liu W, et al. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2021. ↩︎